Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Angeliq
Overview
What is Angeliq?
ANGELIQ
Drospirenone, (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3´,4´,6, 6a,7,8,9,10,11,12,13,14,15,15a,16-hexadecahydro-10,13-dimethylspiro-[ 17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene- 17,2´(5H)-furan]-3,5´(2H)-dione (CAS) is a synthetic progestational compound and has a molecular weight of 366.5 and a molecular formula of CHO.
Estradiol USP, (Estra-1,3,5(10)-triene-3,17-diol,17ß), has a molecular weight of 272.39 and the molecular formula is CHO. The structural formulas are as follows:
What does Angeliq look like?
What are the available doses of Angeliq?
Sorry No records found.
What should I talk to my health care provider before I take Angeliq?
Sorry No records found
How should I use Angeliq?
ANGELIQ
1. Treatment of moderate to severe vasomotor symptoms associated with the menopause.
2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
The dosage of is one tablet daily. Women who are already using a product containing estrogen should stop taking that product before starting .
Use of estrogen, alone or in combination with a progestin, should be limited to the lowest effective dose available and for the shortest duration consistent with treatment goals and risks for the individual woman. Patients should be reevaluated periodically as clinically appropriate (e.g., 3-month to 6-month intervals) to determine if treatment is still necessary (see Boxed Warnings and sections). For women who have a uterus, adequate diagnostic measures, such as endometrial sampling, when indicated, should be undertaken to rule out malignancy in cases of undiagnosed persistent or recurring abnormal vaginal bleeding.
The lowest effective dose of has not been determined.
What interacts with Angeliq?
Sorry No Records found
What are the warnings of Angeliq?
Sorry No Records found
What are the precautions of Angeliq?
Sorry No Records found
What are the side effects of Angeliq?
Sorry No records found
What should I look out for while using Angeliq?
Progestogens/estrogens should not be used in individuals with any of the following conditions:
1. Undiagnosed abnormal genital bleeding.
2. Known, suspected, or history of cancer of the breast.
3. Known or suspected estrogen-dependent neoplasia.
4. Active deep vein thrombosis, pulmonary embolism or history of these conditions.
5. Active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction).
6. Renal insufficiency.
7. Liver dysfunction or disease.
8. Adrenal insufficiency.
9. should not be used in patients with known hypersensitivity to its ingredients.
10. Known or suspected pregnancy. There is no indication for in pregnancy. There appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy. (See ).
ANGELIQ contains 0.5 mg of the progestin drospirenone that has antialdosterone activity, including the potential for hyperkalemia in high-risk patients.
ANGELIQ should not be used in patients with conditions that predispose to hyperkalemia (i.e. renal insufficiency, hepatic dysfunction, and adrenal insufficiency).
Use caution when prescribing ANGELIQ to women who regularly take other medications that can increase potassium, such as NSAIDs, potassium-sparing diuretics, potassium supplements, ACE inhibitors, angiotensin-II receptor antagonists, and heparin. Consider checking serum potassium levels during the first treatment cycle in high-risk patients.
See Boxed Warnings .
What might happen if I take too much Angeliq?
In cases of overdose, monitor serum concentrations of potassium and sodium since drospirenone has antimineralocorticoid properties.
Serious ill effects have not been reported following acute ingestion of large doses of progestin/estrogen-containing oral contraceptives by young children. Overdosage may cause nausea and withdrawal bleeding may occur in females.
How should I store and handle Angeliq?
Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].ANGELIQ TABLETS1 blisters of 28 tablets NDC 54868-6184-0 Storage Conditions Store at 25° C (77° F); excursions permitted to 1530° C (5986° F) [See USP Controlled Room Temperature]. REFERENCES FURNISHED UPON REQUESTANGELIQ TABLETS1 blisters of 28 tablets NDC 54868-6184-0 Storage Conditions Store at 25° C (77° F); excursions permitted to 1530° C (5986° F) [See USP Controlled Room Temperature]. REFERENCES FURNISHED UPON REQUESTANGELIQ TABLETS1 blisters of 28 tablets NDC 54868-6184-0 Storage Conditions Store at 25° C (77° F); excursions permitted to 1530° C (5986° F) [See USP Controlled Room Temperature]. REFERENCES FURNISHED UPON REQUESTANGELIQ TABLETS1 blisters of 28 tablets NDC 54868-6184-0 Storage Conditions Store at 25° C (77° F); excursions permitted to 1530° C (5986° F) [See USP Controlled Room Temperature]. REFERENCES FURNISHED UPON REQUESTANGELIQ TABLETS1 blisters of 28 tablets NDC 54868-6184-0 Storage Conditions Store at 25° C (77° F); excursions permitted to 1530° C (5986° F) [See USP Controlled Room Temperature]. REFERENCES FURNISHED UPON REQUEST
